Systemic Lupus Erythematosus (SLE) diagnosed during hospitalization:greater disease activity, damage and short-term death

被引：0
|
作者：
Hassan, R. I. [1 ]
Porta, S. [1 ]
Aquino, V. [1 ]
Estrella, N. [1 ]
Sequeira, G. [1 ]
Kerzberg, E. [1 ]
机构：
[1] Hosp JM Ramos Mejia, Serv Reumatol, Buenos Aires, DF, Argentina
来源：
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY | 2015年 / 33卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P5.52
引用
收藏
页码：S52 / S52
页数：1
相关论文
共 50 条
  • [1] Impact of severe neuropsychiatric (SNP) manifestations on short-term irreversible damage in systemic lupus erythematosus (SLE).
    Fragoso-Loyo, HE
    Orozco-Narváez, A
    Dávila, L
    Sánchez-Guerrero, FJ
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S381 - S381
  • [2] Disease activity, cumulative damage and quality of life in systemic lupus erythematosus (SLE).
    Hanly, JG
    ARTHRITIS AND RHEUMATISM, 1996, 39 (09): : 264 - 264
  • [3] SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) DIAGNOSED DURING HOSPITALIZATION: CLINICAL PHENOTYPE AND PERFORMANCE OF THE SLE RISK PROBABILITY INDEX (SLERPI)
    Kapsala, N.
    Nikolopoulos, D.
    Flouda, S.
    Chavatza, K.
    Pieta, A.
    Grivas, A.
    Ntourou, A.
    Togia, K.
    Rapsomaniki, P.
    Gerogianni, T.
    Tseronis, D.
    Aggelakos, M.
    Karageorgas, T.
    Katsimpri, P.
    Bertsias, G.
    Fanouriakis, A.
    Boumpas, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 631 - 631
  • [4] Effect of severe neuropsychiatric manifestations on short-term damage in systemic lupus erythematosus
    Fragoso-Loyo, Hilda E.
    Sanchez-Guerrero, Jorge
    JOURNAL OF RHEUMATOLOGY, 2007, 34 (01) : 76 - 80
  • [5] Short-term clinical observations of belimumab in the treatment of recently diagnosed systemic lupus erythematosus
    Wu, Chunye
    Gong, Baoqi
    IMMUNITY INFLAMMATION AND DISEASE, 2022, 10 (11)
  • [6] ASSESSMENT OF DISEASE ACTIVITY IN SYSTEMIC LUPUS-ERYTHEMATOSUS (SLE)
    WINFIELD, JB
    BRUNNER, CM
    DAVIS, JS
    OBRIEN, WM
    ARTHRITIS AND RHEUMATISM, 1972, 15 (04): : 462 - &
  • [7] The effect of race on disease activity in systemic lupus erythematosus (SLE).
    Ghaussy, NO
    Sibbitt, WL
    Bankhurst, AD
    Qualls, CR
    JOURNAL OF INVESTIGATIVE MEDICINE, 2003, 51 : S143 - S143
  • [8] DISEASE ACTIVITY INDICES (DAIS) IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
    Wyrwich, K.
    Winnette, R.
    Oglesby, A.
    Narayanan, S.
    VALUE IN HEALTH, 2012, 15 (07) : A508 - A508
  • [9] Systemic lupus erythematosus: Rituximab improves SLE disease activity
    Onuora S.
    Nature Reviews Rheumatology, 2018, 14 (2) : 62 - 62
  • [10] Fibromyalgia (FM) and disease activity in systemic lupus erythematosus (SLE).
    Petri, M
    Minor, M
    Magder, L
    ARTHRITIS AND RHEUMATISM, 1998, 41 (09): : S332 - S332
12345